[1] PEDERSON T. The ribosome: A structural biology triumph offering new horizons[J]. Faseb j, 2019, 33(4): 4655-4656. doi:  10.1096/fj.190401ufm
[2] KANG J, BRAJANOVSKI N, CHAN K T, et al. Ribosomal proteins and human diseases: Molecular mechanisms and targeted therapy[J]. Signal Transduct Target Ther, 2021, 6(1): 323. doi:  10.1038/s41392-021-00728-8
[3] NISSEN P, HANSEN J, BAN N, et al. The structural basis of ribosome activity in peptide bond synthesis[J]. Science, 2000, 289(5481): 920-930. doi:  10.1126/science.289.5481.920
[4] PETIBON C, MALIK GHULAM M, CATALA M, et al. Regulation of ribosomal protein genes: An ordered anarchy[J]. Wiley Interdiscip Rev RNA, 2021, 12(3): e1632.
[5] DALLA VENEZIA N, VINCENT A, MARCEL V, et al. Emerging role of eukaryote ribosomes in translational control[J]. Int J Mol Sci, 2019, 20(5): 1226. doi:  10.3390/ijms20051226
[6] ROFEAL M, EL-MALEK F A. Ribosomal proteins as a possible tool for blocking sars-cov 2 virus replication for a potential prospective treatment[J]. Med Hypotheses, 2020, 143: 109904. doi:  10.1016/j.mehy.2020.109904
[7] TAKEI S, TOGO-OHNO M, SUZUKI Y, et al. Evolutionarily conserved autoregulation of alternative pre-mrna splicing by ribosomal protein L10a[J]. Nucleic Acids Res, 2016, 44(12): 5585-5596. doi:  10.1093/nar/gkw152
[8] KIM J, KIM Y S. Effect of HIV-1 Tat on the formation of the mitotic spindle by interaction with ribosomal protein S3[J]. Sci Rep, 2018, 8(1): 8680. doi:  10.1038/s41598-018-27008-w
[9] YI Y W, YOU K S, PARK J S, et al. Ribosomal protein S6: a potential therapeutic target against cancer?[J]. Int J Mol Sci, 2021, 23(1): 48. doi:  10.3390/ijms23010048
[10] QI Y K, LI X, CHANG C K, et al. Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome[J]. Sci Rep, 2017, 7(1): 2323. doi:  10.1038/s41598-017-02403-x
[11] OGAWA L M, BASERGA S J. Crosstalk between the nucleolus and the DNA damage response[J]. Mol Biosyst, 2017, 13(3): 443-455. doi:  10.1039/C6MB00740F
[12] DU C W, WANG T N, JIA J N, et al. Suppression of RPL34 inhibits tumor cell proliferation and promotes apoptosis in glioblastoma[J]. Appl Biochem Biotechnol, 2022, 194(8): 3494-3506. doi:  10.1007/s12010-022-03857-0
[13] SUN Z Q, QIU Z G, WANG Z K, et al. Silencing ribosomal protein L22 promotes proliferation and migration, and inhibits apoptosis of gastric cancer cells by regulating the murine double minute 2-protein 53 (mdm2-p53) signaling pathway[J]. Med Sci Monit, 2021, 27: e928375.
[14] XIE C J, CAO K, PENG D X, et al. RPLP1 is highly expressed in hepatocellular carcinoma tissues and promotes proliferation, invasion and migration of human hepatocellular carcinoma Hep3b cells[J]. Exp Ther Med, 2021, 22(1): 752. doi:  10.3892/etm.2021.10184
[15] JI P G, WANG L, LIU J H, et al. Knockdown of rpl34 inhibits the proliferation and migration of glioma cells through the inactivation of jak/stat3 signaling pathway[J]. J Cell Biochem, 2019, 120(3): 3259-3267. doi:  10.1002/jcb.27592
[16] MICALIZZI D S, EBRIGHT R Y, HABER D A, et al. Translational regulation of cancer metastasis[J]. Cancer Res, 2021, 81(3): 517-524. doi:  10.1158/0008-5472.CAN-20-2720
[17] GUO P Y, WANG Y, DAI C X, et al. Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced fgf18 expression in hepatocellular carcinoma[J]. Oncogene, 2018, 37(9): 1220-1236. doi:  10.1038/s41388-017-0017-y
[18] NI C, BUSZCZAK M. Ribosome biogenesis and function in development and disease[J]. Development, 2023, 8(1): 15.
[19] JANG S, LEE J, MATHEWS J, et al. The drosophila ribosome protein S5 paralog RpS5b promotes germ cell and follicle cell differentiation during oogenesis[J]. Development, 2021, 148(19): dev199511. doi:  10.1242/dev.199511
[20] DANILOVA N, WILKES M, BIBIKOVA E, et al. Innate immune system activation in zebrafish and cellular models of Diamond Blackfan anemia[J]. Sci Rep, 2018, 8(1): 5165. doi:  10.1038/s41598-018-23561-6
[21] DANILOVA N, BIBIKOVA E, COVEY T M, et al. The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia[J]. Dis Model Mech, 2014, 7(7): 895-905.
[22] SONG B, ZHANG Q, ZHANG Z, et al. Systematic transcriptome analysis of the zebrafish model of Diamond-Blackfan anemia induced by RPS24 deficiency[J]. BMC Genomics, 2014, 15(1): 759. doi:  10.1186/1471-2164-15-759
[23] ANTUNES A T, GOOS Y J, PEREBOOM T C, et al. Ribosomal protein mutations result in constitutive p53 protein degradation through impairment of the akt pathway[J]. PLoS Genet, 2015, 11(7): e1005326. doi:  10.1371/journal.pgen.1005326
[24] XUE J Q, CHEN L, CHENG H, et al. The identification and validation of hub genes associated with acute myocardial infarction using weighted gene Co-expression network analysis[J]. J Cardiovasc Dev Dis, 2022, 9(1): 30. doi:  10.3390/jcdd9010030
[25] CHEN Y, CHEN Y H, TANG C H, et al. RPS4Y1 promotes high glucose-induced endothelial cell apoptosis and inflammation by activation of the p38 MAPK signaling[J]. Diabetes Metab Syndr Obes, 2021, 14: 4523-4534. doi:  10.2147/DMSO.S329209
[26] LEE J H, LIST A, SALLMAN D A. Molecular pathogenesis of myelodysplastic syndromes with deletion 5q[J]. Eur J Haematol, 2019, 102(3): 203-209. doi:  10.1111/ejh.13207
[27] BOLZE A, BOISSON B, BOSCH B, et al. Incomplete penetrance for isolated congenital asplenia in humans with mutations in translated and untranslated rpsa exons[J]. Proc Natl Acad Sci USA, 2018, 115(34): E8007-e8016.
[28] SHI R, LIU Z R. RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway[J]. Cancer Cell Int, 2022, 22(1): 150. doi:  10.1186/s12935-022-02555-5
[29] LI H Y, ZHANG H, HUANG G M, et al. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells[J]. J Exp Clin Cancer Res, 2022, 41(1): 33. doi:  10.1186/s13046-021-02230-z
[30] ORŠOLIĆ I, BURSAĆ S, JURADA D, et al. Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint[J]. Oncogene, 2020, 39(17): 3443-3457. doi:  10.1038/s41388-020-1231-6
[31] SMOLOCK E M, KORSHUNOV V A, GLAZKO G, et al. Ribosomal protein L17, RpL17, is an inhibitor of vascular smooth muscle growth and carotid intima formation[J]. Circulation, 2012, 126(20): 2418-2427. doi:  10.1161/CIRCULATIONAHA.112.125971
[32] EL KHOURY W, NASR Z. Deregulation of ribosomal proteins in human cancers[J]. Biosci Rep, 2021, 41(12): BSR20211577. doi:  10.1042/BSR20211577
[33] LIU Y, DAHL M, DEBNATH S, et al. Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34(+) cord blood hematopoietic stem cells using a clinically applicable lentiviral vector[J]. Haematologica, 2022, 107(2): 446-456.
[34] ORGEBIN E, LAMOUREUX F, ISIDOR B, et al. Ribosomopathies: new therapeutic perspectives[J]. Cells, 2020, 9(9): 2080. doi:  10.3390/cells9092080
[35] PARK I, PHAN T M, FANG J. Novel molecular mechanism of lenalidomide in myeloid malignancies independent of deletion of chromosome 5q[J]. Cancers, 2021, 13(20): 5084. doi:  10.3390/cancers13205084
[36] WU Z K, WEI W Y, FAN H Z, et al. Integrated analysis of competitive endogenous RNA networks in acute ischemic stroke[J]. Front Genet, 2022, 13: 833545. doi:  10.3389/fgene.2022.833545
[37] KIM J W, YIN X L, MARTIN I, et al. Dysregulated mRNA translation in the G2019S LRRK2 and LRRK2 knock-out mouse brains[J]. eNeuro, 2021, 8(6): ENEURO. 0310-ENEURO. 0321.2021.
[38] LV J, HUANG X R, KLUG J, et al. Ribosomal protein s19 is a novel therapeutic agent in inflammatory kidney disease[J]. Clin Sci (Lond), 2013, 124(10): 627-637. doi:  10.1042/CS20120526
[39] KONG Y Z, CHEN Q Y, LAN H Y. Macrophage migration inhibitory factor (MIF) as a stress molecule in renal inflammation[J]. Int J Mol Sci, 2022, 23(9): 4908. doi:  10.3390/ijms23094908
[40] JACOBS R Q, HUFFINES A K, LAIHO M, et al. The small-molecule BMH-21 directly inhibits transcription elongation and DNA occupancy of rna polymerase i in vivo and in vitro[J]. J Biol Chem, 2022, 298(1): 101450. doi:  10.1016/j.jbc.2021.101450
[41] ZHANG J, LIU W, JI P, et al. Silencing of long chain noncoding RNA paternally expressed gene (PEG10) inhibits the progression of neuroblastoma by regulating microRNA-449a (miR-449a)/ribosomal protein s2 (RPS2) axis[J]. Bioengineered, 2022, 13(3): 6309-6322. doi:  10.1080/21655979.2022.2042999
[42] LI Y M, ZHOU Y, LI B F, et al. WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5-MDM2-p53 pathway[J]. Oncogene, 2020, 39(13): 2741-2755. doi:  10.1038/s41388-020-1179-6
[43] PECORARO A, PAGANO M, RUSSO G, et al. Ribosome biogenesis and cancer: overview on ribosomal proteins[J]. Int J Mol Sci, 2021, 22(11): 5496. doi:  10.3390/ijms22115496
[44] GAO Y, LI F Y, ZHOU H, et al. Down-regulation of MRPS23 inhibits rat breast cancer proliferation and metastasis[J]. Oncotarget, 2017, 8(42): 71772-71781. doi:  10.18632/oncotarget.17888
[45] HAO C Y, DUAN H B, LI H, et al. Knockdown of mrpl42 suppresses glioma cell proliferation by inducing cell cycle arrest and apoptosis[J]. Biosci Rep, 2018, 38(2): BSR20171456. doi:  10.1042/BSR20171456
[46] ZHANG L, LU P, YAN L, et al. MRPL35 is up-regulated in colorectal cancer and regulates colorectal cancer cell growth and apoptosis[J]. Am J Pathol, 2019, 189(5): 1105-1120. doi:  10.1016/j.ajpath.2019.02.003
[47] WANG Z, LI J J, LONG X B, et al. MRPS16 facilitates tumor progression via the PI3K/AKT/Snail signaling axis[J]. J Cancer, 2020, 11(8): 2032-2043. doi:  10.7150/jca.39671
[48] YU M J, ZHAO N, SHEN H B, et al. Long noncoding RNA MRPL39 inhibits gastric cancer proliferation and progression by directly targeting miR-130[J]. Genet Test Mol Biomarkers, 2018, 22(11): 656-663. doi:  10.1089/gtmb.2018.0151
[49] TANG N Y, CHUEH F S, YU C C, et al. Benzyl isothiocyanate alters the gene expression with cell cycle regulation and cell death in human brain glioblastoma GBM 8401 cells[J]. Oncol Rep, 2016, 35(4): 2089-2096. doi:  10.3892/or.2016.4577
[50] CHANG Y, HE J G, TANG J Q, et al. Investigation of the gene co-expression network and hub genes associated with acute mountain sickness[J]. Hereditas, 2020, 157(1): 13. doi:  10.1186/s41065-020-00127-z